首页 | 本学科首页   官方微博 | 高级检索  
     

急性缺血性卒中血管再通治疗后早期神经功能恶化研究进展
引用本文:柳洁,夏盼,潘春华,李航,王泽颖. 急性缺血性卒中血管再通治疗后早期神经功能恶化研究进展[J]. 天津医药, 2022, 50(11): 1227-1232. DOI: 10.11958/20220310
作者姓名:柳洁  夏盼  潘春华  李航  王泽颖
作者单位:1 潍坊医学院(邮编261042)2 山东中医药大学3 潍坊市中医院
基金项目:山东省名老中医药专家传承工作室建设项目(鲁卫函[2019]92号);齐鲁医派中医学术流派传承项目(鲁卫函[2020]132号);潍坊市2020年科技发展计划项目(2020YX019)
摘    要:血管再通治疗已成为急性缺血性卒中(AIS)的有效治疗方法,但由于出血转化、不良再灌注、血管再闭塞等各种因素的影响,有部分AIS患者在接受血管再通治疗后会出现早期神经功能恶化(END),主要表现为病情进展、神经功能损伤加重,严重影响患者预后。目前END尚无统一的名称及诊断标准,有关再通治疗后END的研究结果亦不尽相同。就再通治疗后END发病机制、危险因素以及预测因子等相关内容进行综述。

关 键 词:卒中  急性缺血性卒中  血管内治疗  静脉溶栓  早期神经功能恶化  综述
收稿时间:2022-03-02
修稿时间:2022-06-14

Research progress on early neurological deterioration after vascular recanalization in acute ischemic stroke
LIU Jie,XIA Pan,PAN Chunhua,LI Hang,WANG Zeying. Research progress on early neurological deterioration after vascular recanalization in acute ischemic stroke[J]. Tianjin Medical Journal, 2022, 50(11): 1227-1232. DOI: 10.11958/20220310
Authors:LIU Jie  XIA Pan  PAN Chunhua  LI Hang  WANG Zeying
Affiliation:1 Weifang Medical College, Weifang 261042, China
2 Shandong University of Traditional Chinese Medicine
3 Weifang Hospital of Traditional Chinese Medicine
Abstract:Recanalization therapy has become an effective treatment for acute ischemic stroke (AIS), but due to the influence of various factors such as bleeding transformation, poor reperfusion and vascular reocclusion, some AIS patients will experience early neurological deterioration (END) after recanalization therapy, which is mainly manifested as disease progression and aggravated neurological impairment, seriously affecting the prognosis of patients. At present, there is no uniform name and diagnostic criteria for END, and results of studies on END after recanalization therapy are also different. This article reviews the pathogenesis, risk factors and predictors of END after recanalization therapy.
Keywords:stroke  acute ischemic stroke  endovascular treatment  intravenous thrombolysis  early neurologic deterioration  review  
点击此处可从《天津医药》浏览原始摘要信息
点击此处可从《天津医药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号